Michael J. Reardon

Michael J. Reardon, MD

Allison Family Distinguished Chair In Cardiovascular Research, Department of Cardiovascular Surgery
Professor of Cardiovascular Surgery, Academic Institute
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Dr. Michael J. Reardon is a native Houstonian who attended Baylor College of Medicine where he graduated with honors and as a member of AOA. He did his general surgery residency under Dr. Michael DeBakey and cardiothoracic residency under Dr. Denton Cooley. He joined the staff of the Houston Methodist Hospital in 1985 and ran a private practice until 1993. He then joined the full time faculty of BCM rising to Professor of Surgery with tenure, Chief of Cardiothoracic Surgery and Director of the thoracic residency program. He subsequently joined the academic group at the HMH as Professor of Cardiothoracic Surgery and Chief of Cardiac Surgery.

His interests have centered on aortic surgery, cardiac valve surgery and cardiac tumors. His recent research and clinical interests have focused on minimally invasive, catheter-based approaches to these areas. He serves on the national steering committee for the CoreValve, SurTAVI and reprise III TAVR trials and as national surgical PI on the SurTAVI trial, reprise III trial and the Gore type A dissection trial. Dr. Reardon also serves as the international surgical PI for the Reprise III trial.

He holds the position of Clinical Professor of Cardiothoracic Surgery at MD Anderson Cancer Center and created the multi-institution, multidisciplinary cardiac tumor team with HMH and MDA. He has operated on more primary cardiac sarcomas than any other surgeon globally and written extensively on this topic. Dr. Reardon's group recently published the largest series of surgically treated primary cardiac sarcomas in the world. Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience PMID 26476808

He has served as elected president of the medical staff for the HMH and received numerous awards including the Overstreet Award and Noon Award. He currently holds the Allison Family Distinguished Chair of Cardiovascular Research and divides his time between building innovative clinical, research and educational programs.

Description of Research

He has been the principal and co-investigator on several industry and government-sponsored clinical trials and research initiatives, and he is currently on the national steering and screening committees for the Medtronic CoreValve US Pivotal Trial and the international steering committee for the SurTAVI Trial, for which he is also a national surgical principal investigator. His research interests include cardiac tumor treatment, catheter based approaches to structural heart disease, catheter based and open aortic disease treatment Having published more than 300 articles and abstracts, Dr. Reardon conducts peer reviews for publications such as the Annals of Thoracic Surgery and Circulation and is the associate editor of surgery for the Methodist DeBakey Cardiovascular Journal.

Areas Of Expertise

Cardiac tumor treatment Catheter based approaches to structural heart disease Catheter based and open aortic disease treatments Cardiac valve disease Aortic surgery Cardiac tumor surgery Complex cardiac surgery
Education & Training

MD, Baylor College of Medicine
Residency, Baylor College of Medicine
Certificate, Healthcare Management, Rice University
Fellow, Harvard University Alley-Sheridan School of Government
Residency, Texas Heart Institute
Active Clinical Trials

PERIGON Pivotal Trial



At the Edge of Knowledge
Reardon, MJ 2022, , Annals of Thoracic Surgery, vol. 114, no. 6, pp. e435. https://doi.org/10.1016/j.athoracsur.2022.01.066

Does Size Matter?
Atkins, MD & Reardon, MJ 2022, , Annals of Thoracic Surgery, vol. 114, no. 6, pp. 2260-2261. https://doi.org/10.1016/j.athoracsur.2021.11.024

Surgical Salvage of Annular Rupture After Transcatheter Aortic Valve Implantation by Conversion Into Annular Enlargement
El Nihum, LI, Al Abri, Q, Telmesani, A, Ali, A, He, YA, Hinohara, T, Reyes, M, Ramchandani, M & Reardon, MJ 2022, , JACC: Case Reports, vol. 4, no. 22, pp. 1529-1533. https://doi.org/10.1016/j.jaccas.2022.08.014

Late Transcatheter Aortic Valve Thrombosis Leading to Cardiogenic Shock
Al Abri, Q, El Nihum, LI, Hinohara, T, Chang, SM, Faza, NN, Goel, SS, Kleiman, NS, Wyler von Ballmoos, MC, Atkins, MD & Reardon, MJ 2022, , JACC: Case Reports, vol. 4, no. 22, pp. 1459-1463. https://doi.org/10.1016/j.jaccas.2022.07.032

Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial
Rizik, DG, Rajagopal, V, Makkar, RR, Bajwa, T, Kleiman, NS, Linke, A, Kereiakes, DJ, Waksman, R, Thourani, VH, Stoler, RC, Mishkel, GJ, Iyer, VS, Buchbinder, M, Götberg, M, Bjursten, H, Allocco, DJ & Reardon, MJ 2022, , JAMA Network Open, vol. 5, no. 10, e2238792, pp. E2238792. https://doi.org/10.1001/jamanetworkopen.2022.38792

Surgical aortic valve replacement with a stented pericardial bioprosthesis: 5-year outcomes
On behalf of the PERIGON Investigators 2022, , European Journal of Cardio-thoracic Surgery, vol. 62, no. 3, ezac374. https://doi.org/10.1093/ejcts/ezac374

Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review
Heart Valve Collaboratory 2022, , Journal of the American College of Cardiology, vol. 80, no. 5, pp. 545-561. https://doi.org/10.1016/j.jacc.2022.06.002

Déjà Vu: a new surgical disease
Al Abri, Q & Reardon, MJ 2022, , European Journal of Cardio-thoracic Surgery, vol. 62, no. 2, ezac390. https://doi.org/10.1093/ejcts/ezac390

Papillary Fibroelastoma Incidentally Found on Left Atrial Wall During Minimally Invasive Aortic Valve Replacement
Abri, QA, El Nihum, LI, Zubair, MM, Barrios, R, Reardon, MJ & Ramchandani, M 2022, , Texas Heart Institute Journal, vol. 49, no. 4, e217725. https://doi.org/10.14503/THIJ-21-7725

Quality of Life after Fractional Flow Reserve-Guided PCI Compared with Coronary Bypass Surgery
Fearon, WF, Zimmermann, FM, Ding, VY, Zelis, JM, Piroth, Z, Davidavicius, G, Mansour, S, Kharbanda, R, Östlund-Papadogeorgos, N, Oldroyd, KG, Wendler, O, Reardon, MJ, Woo, YJ, Yeung, AC, Pijls, NHJ, De Bruyne, B, Desai, M & Hlatky, MA 2022, , Circulation, vol. 145, no. 22, pp. 1655-1662. https://doi.org/10.1161/CIRCULATIONAHA.122.060049

Characteristics and outcomes of patients screened for transcatheter mitral valve implantation: 1-year results from the CHOICE-MI registry
CHOICE-MI Investigators 2022, , European Journal of Heart Failure, vol. 24, no. 5, pp. 887-898. https://doi.org/10.1002/ejhf.2492

Functional Status After Transcatheter and Surgical Aortic Valve Replacement: 2-Year Analysis From the SURTAVI Trial
Tuttle, MK, Kiaii, B, Van Mieghem, NM, Laham, RJ, Deeb, GM, Windecker, S, Chetcuti, S, Yakubov, SJ, Chawla, A, Hockmuth, D, Teefy, P, Li, S & Reardon, MJ 2022, , JACC: Cardiovascular Interventions, vol. 15, no. 7, pp. 728-738. https://doi.org/10.1016/j.jcin.2022.01.284

Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in the United States and Japan: A Report From Joint Data Harmonization Initiative of STS/ACC TVT and J-TVT
Kaneko, T, Vemulapalli, S, Kohsaka, S, Shimamura, K, Stebbins, A, Kumamaru, H, Nelson, AJ, Kosinski, A, Maeda, K, Bavaria, JE, Saito, S, Reardon, MJ, Kuratani, T, Popma, JJ, Inohara, T, Thourani, VH, Carroll, JD, Shimizu, H, Takayama, M, Leon, MB, Mack, MJ & Sawa, Y 2022, , Journal of the American Heart Association, vol. 11, no. 6, e023848. https://doi.org/10.1161/JAHA.121.023848

Propensity-Matched 1-Year Outcomes Following Transcatheter Aortic Valve Replacement in Low-Risk Bicuspid and Tricuspid Patients
Deeb, GM, Reardon, MJ, Ramlawi, B, Yakubov, SJ, Chetcuti, SJ, Kleiman, NS, Mangi, AA, Zahr, F, Song, HK, Gada, H, Mumtaz, M, Heiser, J, Merhi, W, Murrah, CP, Noel, T, Kirshner, M, Byrne, T, Ito, S, Huang, J & Forrest, JK 2022, , JACC: Cardiovascular Interventions, vol. 15, no. 5, pp. 511-522. https://doi.org/10.1016/j.jcin.2021.10.027

2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients
Forrest, JK, Deeb, GM, Yakubov, SJ, Rovin, JD, Mumtaz, M, Gada, H, OHair, D, Bajwa, T, Sorajja, P, Heiser, JC, Merhi, W, Mangi, A, Spriggs, DJ, Kleiman, NS, Chetcuti, SJ, Teirstein, PS, Zorn, GL, Tadros, P, Tchétché, D, Resar, JR, Walton, A, Gleason, TG, Ramlawi, B, Iskander, A, Caputo, R, Oh, JK, Huang, J & Reardon, MJ 2022, , Journal of the American College of Cardiology, vol. 79, no. 9, pp. 882-896. https://doi.org/10.1016/j.jacc.2021.11.062

Current and future transcatheter aortic valve replacement valves
Eikelboom, R, Moran, RM, Yan, W, Yamashita, M, Patel, A, Reardon, M & Spooner, A 2022, , Current Opinion in Cardiology, vol. 37, no. 2, pp. 173-179. https://doi.org/10.1097/HCO.0000000000000935

Large, Hormonally Active Primary Cardiac Paraganglioma: Diagnosis and Management
Zubair, MM, El Nihum, LI, Haley, SL, Al Abri, Q, Lenihan, DJ, MacGillivray, TE & Reardon, MJ 2022, , Annals of Thoracic Surgery, vol. 113, no. 3, pp. e167-e170. https://doi.org/10.1016/j.athoracsur.2021.05.042

Commentary: Does this model reality?
Faza, NN & Reardon, MJ 2022, , JTCVS Open, vol. 9, pp. 39-40. https://doi.org/10.1016/j.xjon.2022.02.003

Fractional flow reserve–guided PCI as compared with coronary bypass surgery
for the FAME 3 Investigators 2022, , New England Journal of Medicine, vol. 386, no. 2, pp. 128-137. https://doi.org/10.1056/NEJMoa2112299

30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results
Zahr, F, Song, HK, Chadderdon, SM, Gada, H, Mumtaz, M, Byrne, T, Kirshner, M, Bajwa, T, Weiss, E, Kodali, S, George, I, Heiser, J, Merhi, WM, Thaden, JJ, Zhang, A, Lim, DS, Reardon, MJ, Adams, DH, Mack, MJ & Leon, MB 2022, , JACC: Cardiovascular Interventions, vol. 15, no. 1, pp. 80-89. https://doi.org/10.1016/j.jcin.2021.10.018